Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole prolonged-release bioequivalence and tolerability crossover study in healthy volunteers
NL-OMON36833Active, not recruiting
- Sponsor
- Synthon
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pramipexole in Parkinson's disease (PD) (2 arms), sponsored by Synthon. Primary endpoints: Safety, Tolerability and 1 more. Started Aug 2012; status: active, not recruiting.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON36833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36833.